Results 171 to 180 of about 274,722 (228)
Some of the next articles are maybe not open access.

Epicutaneous immunotherapy: A review of safety and efficacy

Pediatric Allergy and Immunology
Epcutaneous immunotherapy (EPIT) is a novel, non‐oral route of allergen immunotherapy, utilizing the skin and its robust density of epidermal Langerhans cells (LC) for antigen presentation.
A. Anagnostou, M. Greenhawt
semanticscholar   +3 more sources

Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy

Drug Delivery and Translational Research, 2023
Allergen-specific immunotherapy (SIT) is a desirable way of therapy for various allergic diseases such as food allergy (FA). However, frequent visits for more than 3 years and potential adverse effects often hinder patient compliance. Recently, many researchers started focusing on microneedles (MNs) as a new method for SIT.
Erkang Zhang   +4 more
semanticscholar   +3 more sources

Engineered Iontophoresis Patch for Epicutaneous Allergen‐specific Immunotherapy

Advanced Functional Materials
Epidermal immunotherapy represents an emerging treatment method for allergic diseases. Nevertheless, an unformidable obstacle for epidermal drug delivery is the dense stratum corneum of the skin.
Zhiting Cao   +7 more
semanticscholar   +2 more sources

Challenging the norm: Epicutaneous immunotherapy for canine atopic dermatitis

Allergy, 2023
Marta Pinto   +10 more
semanticscholar   +3 more sources

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.

New England Journal of Medicine, 2023
BACKGROUND No approved treatment for peanut allergy exists for children younger than 4 years of age, and the efficacy and safety of epicutaneous immunotherapy with a peanut patch in toddlers with peanut allergy are unknown.
M. Greenhawt   +65 more
semanticscholar   +1 more source

Severity of eczema at patch site during epicutaneous immunotherapy may predict subsequent response to oral immunotherapy.

Journal of Allergy and Clinical Immunology: In Practice, 2023
CLINICAL IMPLICATIONS BOX Severity of eczema at patch application site during epicutaneous immunotherapy could be an independent predictor of subsequent response to oral immunotherapy.
Camille Braun   +6 more
semanticscholar   +1 more source

EPOPEX, EFFICACY AND SAFETY OF EPICUTANEOUS IMMUNOTHERAPY IN PEANUT-ALLERGIC TODDLERS: 1-YEAR OPEN-LABEL EXTENSION TO EPITOPE

Annals of Allergy, Asthma & Immunology, 2023
The treatment ...
M. Greenhawt   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy